DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Thonzylamine
Thonzylamine
(CD-P-PH/PHO) Report Classification/Justifica
Prohibited Substances List
(19) United States (12) Patent Application Publication (10) Pub
236 Subpart A—General Provisions Subpart B—Active Ingredients
Proposed Changes to the 2021 FEI Equine Prohibited Substances List (EPSL) (Effective from 01.01.2022)
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Nasal Decongestant Active Ingredients
209089Orig1s000 209090Orig1s000
Prescription Medications, Drugs, Herbs & Chemicals Associated With
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Comprehensive List of Cross-Reactive and Non Cross-Reactive Compounds
2021 Equine Prohibited Substances List
Ep 2301628 A1
January 2021 Preferred Drug List and PA Criteria
Mdwise Formulary Introduction – Healthy Indiana Plan State (HIP State)
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Top View
(12) United States Patent (10) Patent No.: US 8,882,729 B2 Horstmann Et Al
(HMO SNP) Non-Part D and Over the Counter Medicaid Covered Drugs
207768Orig1s000
Alphabetical Listing by Therapeutic Category Dod UNIFORM
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
Npgrj NCHEMBIO 806 415..416
(12) Patent Application Publication (10) Pub. No.: US 2017/0020873 A1 Mitchell (43) Pub
Prevalence of Psychoactive Substances in the General Population
Pharmaabkommen A1 E
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
Customs Tariff - Schedule Xxi - 1
243 Subpart B—Active Ingredients
Thonzylamine Hydrochloride/Tritoqualine
Ownloaded from Ascelibrary.Org by New York University on 02/16/15
201373Orig1s000
Histamine H1-Receptor Antagonists: Antihistaminic Agents
(12) Patent Application Publication (10) Pub. No.: US 2004/0241219 A1 Hille Et Al
Cough and Cold Therapeutic Class Review
Antihistamines in Topical Preparations
(12) Patent Application Publication (10) Pub. No.: US 2014/0094438 A1 Mitchell (43) Pub
(2) Patent Application Publication (10) Pub. No.: US 2017/0020873 A1 Mitchell (43) Pub
Non-Interventional Study Protocol
Poly-Hist DM Liquid
Table of Drugs and Chemicals (FY12)
Sentinel Report Cder Mpl1r Wp086
United States Patent Office
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
(19) United States (12) Patent Application Publication (10) Pub
International Classification of Procedures in Medicine
AC 91.11-1, Guide to Drug Hazards in Aviation Medicine
(12) United States Patent (10) Patent No.: US 9,050,289 B2 Mitchell (45) Date of Patent: Jun
Poison Or Antibiotic a Guide to Class Entries (English Version Only)
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving